Key facts
- This page summarizes Jonathan B. Bush's Form 4 filing for ModivCare Inc (MODV).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Sep 2023, 16:43.
Jonathan B. Bush - 31 Aug 2023 Form 4 Insider Report for ModivCare Inc (MODV)
- Reporting relationship
- SVP, GC and Secretary
- Issuer ticker
- MODV
- Reported as of
- 31 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Sep 2023, 16:43:00 UTC
- Prior SEC filing
- 21 Jul 2023
- Next SEC filing
- 07 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Bush
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan B. Bush filed Form 4 for ModivCare Inc (MODV) on 05 Sep 2023.
Change
- Previous filing in this sequence was filed on 21 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MODV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,834
- Change %
- +216%
- Price
- $0.000000
- Shares after
- 4,149
- Date
- 31 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MODV
transaction
Derivative
Performance Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +4,252
- Change %
- Price
- $0.000000
- Shares after
- 4,252
- Date
- 31 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,252
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents restricted stock units scheduled to vest as follows: (i) 945 shares will vest on August 31, 2024, (ii) 944 shares will vest on August 31, 2025 and (iii) 945 shares will vest on August 31, 2026, in each case, subject to the reporting person's continued employment.
Footnote F2
Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified revenue and Adjusted EBITDA thresholds measured by reference to the issuer's audited financial statements for its fiscal year ending December 31, 2025, subject to the reporting person's continued employment through the vesting date of August 31, 2026. The number of shares of common stock reported assumes a revenue and Adjusted EBITDA performance target achieved that corresponds to a 100% payout level.